Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
14.86
+0.05 (0.34%)
Feb 3, 2026, 3:04 PM CST

SHE:002907 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
775.83764.14680.84774.72837.23876.09
Other Revenue
10.6810.6810.710.478.916.38
786.51774.82691.54785.18846.14882.47
Revenue Growth (YoY)
-0.51%12.04%-11.93%-7.20%-4.12%4.80%
Cost of Revenue
334.55332.91312.45320.55400.53458.88
Gross Profit
451.96441.91379.1464.63445.61423.59
Selling, General & Admin
305.69308.36263.88292.53297.82269.07
Research & Development
79.3859.1378.1258.8241.7236.48
Other Operating Expenses
27.7710.659.3912.3411.589.82
Operating Expenses
411.53379.55349.7367.04350.65314.47
Operating Income
40.4262.3629.497.5994.95109.13
Interest Expense
---0.95-14.42-18.22-17.21
Interest & Investment Income
24.0210.329.8111.516.414.61
Currency Exchange Gain (Loss)
00-0---
Other Non Operating Income (Expenses)
-16.050.27-0.17-0.03-0.03-0.02
EBT Excluding Unusual Items
48.3972.9538.194.6493.11106.51
Gain (Loss) on Sale of Investments
5.541.38-4.67-2.61-1.331.21
Gain (Loss) on Sale of Assets
8.56-0.06--0.01-0.01
Asset Writedown
0.63-0.03-2.37-0.17--
Other Unusual Items
31.1919.1411.6816.3711.6529.34
Pretax Income
94.3293.4442.8108.24103.42137.05
Income Tax Expense
24.2416.7110.19.8411.6417.86
Earnings From Continuing Operations
70.0776.7332.798.491.78119.19
Minority Interest in Earnings
4.54-----
Net Income
74.6176.7332.798.491.78119.19
Net Income to Common
74.6176.7332.798.491.78119.19
Net Income Growth
19.37%134.66%-66.77%7.21%-22.99%-29.79%
Shares Outstanding (Basic)
418418418403401401
Shares Outstanding (Diluted)
418418418403401401
Shares Change (YoY)
0.05%0.02%3.60%0.49%0.06%0.21%
EPS (Basic)
0.180.180.080.240.230.30
EPS (Diluted)
0.180.180.080.240.230.30
EPS Growth
19.32%134.61%-67.92%6.69%-23.04%-29.93%
Free Cash Flow
67.05145.62126.52-47.5726.2166.95
Free Cash Flow Per Share
0.160.350.30-0.120.070.17
Dividend Per Share
0.0850.0850.0500.0700.0500.028
Dividend Growth
-70.00%-28.57%40.00%78.57%-36.36%
Gross Margin
57.46%57.03%54.82%59.17%52.66%48.00%
Operating Margin
5.14%8.05%4.25%12.43%11.22%12.37%
Profit Margin
9.49%9.90%4.73%12.53%10.85%13.51%
Free Cash Flow Margin
8.53%18.79%18.30%-6.06%3.10%7.59%
EBITDA
127.78147.38111.3172.13164.7156.02
EBITDA Margin
16.25%19.02%16.09%21.92%19.46%17.68%
D&A For EBITDA
87.3585.0181.974.5469.7446.89
EBIT
40.4262.3629.497.5994.95109.13
EBIT Margin
5.14%8.05%4.25%12.43%11.22%12.37%
Effective Tax Rate
25.70%17.89%23.59%9.09%11.25%13.03%
Revenue as Reported
786.51774.82691.54785.18846.14882.47
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.